Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALL-Reference-Cited by-同舟云学术

Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALL

Published:2020-03-17 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Li Si-Qi,Fan Qiao-Zhen,Xu Lan-Ping,Wang Yu,Zhang Xiao-Hui,Chen Huan,Chen Yu-Hong,Wang Feng-Rong,Han Wei,Sun Yu-Qian,Yan Chen-Hua,Tang Fei-Fei,Liu Yan-Rong,Mo Xiao-Dong,Wang Xin-Yu,Liu Kai-Yan,Huang Xiao-Jun,Chang Ying-Jun

Funder

Beijing Municipal Science and Technology Commission

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference60 articles.

1. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia;Arico;New Eng J Med,2000

2. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group;Eckert;J Clin Oncol Offi J Am Soc Clin Oncol,2013

3. Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia;Lee;Leukemia,2005

4. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive all;Rousselot;Blood,2016

5. Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia;Daver;Haematologica,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party;Bone Marrow Transplantation;2024-06-04

2. Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study;Leukemia Research;2024-06

3. Prognostic Factors Impacting Post-Transplant Outcomes in Adult T-cell Acute Lymphoblastic Leukemia: A Registry-Based Study by the EBMT Acute Leukemia Working Party;2024-01-18

5. Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia;Pathogenesis and Treatment of Leukemia;2023